Expertise

Jimmy El Hokayem

Vice President, Business Development, Compliance

Expertise:

Clinical Research, Commercialization, Compliance, Regulatory Compliance

Jimmy, Vice President of Business Development at EVERSANA, brings seasoned experience in basic, translational, and clinical research across the executive, strategic, operational, and managerial levels. He is an expert clinical and business developer with success in scaling biopharma portfolios through business development and strategic partnerships.

Adept at building high-performing teams, ensuring regulatory compliance, and advancing pipeline growth and revenue, Jimmy provides innovative and pragmatic compliance support for small and mid-size biopharma—from due diligence to clinical development cycle and commercialization.

Before joining EVERSANA, Jimmy acquired over twenty years of experience in both academia and clinical research, focused on neurological disease and neuro-oncology. He has published over twenty peer reviewed papers and received multiple awards from international foundations and entities.

Jimmy received his Ph.D. from University of Miami, Miller School of Medicine, in Biochemistry and Molecular Biology. He continued his training with post-doctoral work at the University’s Hussman Institute for Human Genomics where he had impactful contributions on early models of iPSC derivation from PBMCs.

Articles by Jimmy El Hokayem

You Cannot Commercialize What is Not Compliant

Most launch delays don’t start in the clinic—they stem from overlooked gaps in commercial compliance. Complete Response Letters (CRLs), though one of the greatest threats to launch success, are largely preventable with the proper commercial compliance framework. What You’ll Learn in this POV: Why 70% of launches fail The most common gaps cited in FDA-issued […]

Interested in scheduling a meeting or speaking event?

Contact Us